The rate of cardiac injury as determined by cTnI in this study was 19%. In trying to identify any factors that may contribute to an overestimation of cardiac injury, we consider the use of cTnI ...

A research team at UCLA has developed a deep learning-powered chemiluminescence vertical flow assay (CL-VFA) that brings ...

Cardiac troponins are a group of markers used to predict the risk of heart disease. However, it is not well understood how controlling blood pressure affects levels of troponin I and whether the ...

A bracelet-like device that measures levels of troponin-I in the blood could provide a more efficient way of detecting a heart attack, according to US researchers. The wearable developed by RCE ...

Day 90 biopsy data reported from first 3 participants dosed in Phase 1/2 INSPIRE DUCHENNE trial —— Average microdystrophin expression of 110% ...

The following is a summary of “Impact of impaired renal function on kinetics of high-sensitive cardiac troponin following cardiac surgery,” published in the January 2025 issue of Cardiology by Rudolph ...

Switching from a conventional to a high-sensitivity cardiac troponin I assay in emergency departments is associated with a reduction in both mortality at 1 year and new admissions for myocardial ...

Cardiac enzymes ― also known as cardiac biomarkers ― include myoglobin, troponin and creatine kinase. Historically, lactate dehydrogenase, or LDH, was also used but is non-specific.

"High-risk individuals could be evaluated for early biomarkers predictive of future IHD, such as high-sensitive cardiac ...

The "Global Cardiac Biomarkers Diagnostics Industry, 2024-2029" report has been added to ResearchAndMarkets.com's offering. This research service provides an overview of the global cardiac biomarkers ...